688016 Share Price | Shanghai MicroPort Endovascular MedTech Co., Ltd. Stock Analysis & Recommendation

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Dashboard

Negative results in Mar 25

NET PROFIT(HY) At CNY 78.4 MM has Grown at -72.81%
INTEREST(HY) At CNY 1.44 MM has Grown at 74.9%
OPERATING CASH FLOW(Y) Lowest at CNY 230.91 MM

With ROE of 10.02%, it has a expensive valuation with a 3.25 Price to Book Value

Consistent Underperformance against the benchmark over the last 3 years

Mojo Parameters

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

CNY 11,516 Million (Large Cap)

P/E

32.00

Industry P/E

Dividend Yield

1.03%

Debt Equity

-0.54

Return on Equity

9.32%

Price to Book

2.91

Revenue and Profits:

Net Sales:

300 Million

(Quarterly Results - Sep 2025)

Net Profit:

112 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

-0.17%

6 Months

-12.43%

1 Year

-6.01%

2 Years

-2.99%

3 Years

-33.05%

4 Years

-22.11%

5 Years

-48.65%

Shanghai MicroPort Endovascular MedTech Co., Ltd. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

24.57%

EBIT Growth (5y)

17.79%

EBIT to Interest (avg)

100.00

Debt to EBITDA (avg)

Net Debt to Equity (avg)

-0.52

Sales to Capital Employed (avg)

0.36

Tax Ratio

25.31%

Dividend Payout Ratio

48.89%

Pledged Shares

Institutional Holding

ROCE (avg)

74.02%

ROE (avg)

16.77%

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

3.25

EV to EBIT

28.54

EV to EBITDA

23.60

EV to Capital Employed

5.97

EV to Sales

9.68

PEG Ratio

Dividend Yield

1.11%

ROCE (Latest)

20.91%

ROE (Latest)

10.02%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Mildly Bullish

RSI

No Signal

Bollinger Bands

Mildly Bearish

Moving Averages

Mildly Bearish (Daily)

KST

Mildly Bullish

Dow Theory

No Trend

OBV

Mildly Bearish

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot

No data for shareholding present.

Shareholding Compare (%holding)

No data for shareholding present.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Sep'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Sep 2025 is -21.40% vs 15.05% in Jun 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Sep 2025 is -38.44% vs 42.66% in Jun 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Jun'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "300.40",
          "val2": "382.20",
          "chgp": "-21.40%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "115.60",
          "val2": "187.00",
          "chgp": "-38.18%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.70",
          "val2": "0.20",
          "chgp": "250.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "112.40",
          "val2": "182.60",
          "chgp": "-38.44%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "384.90%",
          "val2": "433.20%",
          "chgp": "-4.83%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 1.78% vs 32.36% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 1.13% vs 38.37% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,197.20",
          "val2": "1,176.30",
          "chgp": "1.78%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "577.70",
          "val2": "578.20",
          "chgp": "-0.09%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "2.00",
          "val2": "2.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "56.50",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "492.70",
          "val2": "487.20",
          "chgp": "1.13%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "431.90%",
          "val2": "452.30%",
          "chgp": "-2.04%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Sep'25 - QoQ

Sep'25

Jun'25

Change(%)

Net Sales

300.40

382.20

-21.40%

Operating Profit (PBDIT) excl Other Income

115.60

187.00

-38.18%

Interest

0.70

0.20

250.00%

Exceptional Items

0.00

Consolidate Net Profit

112.40

182.60

-38.44%

Operating Profit Margin (Excl OI)

384.90%

433.20%

-4.83%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Sep 2025 is -21.40% vs 15.05% in Jun 2025

Consolidated Net Profit

QoQ Growth in quarter ended Sep 2025 is -38.44% vs 42.66% in Jun 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'24

Dec'24

Dec'23

Change(%)

Net Sales

1,197.20

1,176.30

1.78%

Operating Profit (PBDIT) excl Other Income

577.70

578.20

-0.09%

Interest

2.00

Exceptional Items

56.50

0.00

Consolidate Net Profit

492.70

487.20

1.13%

Operating Profit Margin (Excl OI)

431.90%

452.30%

-2.04%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2024 is 1.78% vs 32.36% in Dec 2023

Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 1.13% vs 38.37% in Dec 2023

All Annual Results

Company CV

About Shanghai MicroPort Endovascular MedTech Co., Ltd.

Shanghai MicroPort Endovascular MedTech Co., Ltd.

Pharmaceuticals & Biotechnology

No Details Available.

Company Coordinates

No Company Details Available